Paper41398241
Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis.
Li J and 5 others. BMC Neurol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. Papers, record 41398241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398241
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Parkinson Disease | Major topic |
| Sleep Wake Disorders | Major topic |
| Humans | |
| Randomized Controlled Trials as Topic |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| SQ2024AAA031359 | National Science and Technology Major Project | PubMed | ||
| 2023TP1047 | Innovation Platform and Talent Program | PubMed | ||
| 202218014518 | Scientific Research Project of Hunan Provincial Health Commission | PubMed | ||
| 20224310NHYCG03 | Clinical Research 4310 Program of the First Affiliated Hospital of University of South China | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 41668031 | Correction: Sleep disorders in parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. | https://conductscience.org/library/papers/41668031 |
Source PubMed
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40066297 | Dual orexin receptor antagonists as promising therapeutics for Alzheimer's disease. | NPJ Biol Timing Sleep | 2025 | https://conductscience.org/library/papers/40066297 | PubMed |
| 2 | 36897120 | Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS. | Ann Neurol | 2023 | https://conductscience.org/library/papers/36897120 | PubMed |
| 3 | 37761265 | Sleep Disorders Associated with Neurodegenerative Diseases. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37761265 | PubMed |
| 4 | 33714847 | Nelotanserin as symptomatic treatment for rapid eye movement sleep behavior disorder: a double-blind randomized study using video analysis in patients with dementia with Lewy bodies or Parkinson's disease dementia. | Sleep Med | 2021 | https://conductscience.org/library/papers/33714847 | PubMed |
| 5 | 17218758 | Melatonin in humans. | J Physiol Pharmacol | 2006 | https://conductscience.org/library/papers/17218758 | PubMed |
| 6 | 36045942 | Daridorexant for the Treatment of Insomnia. | Health Psychol Res | 2022 | https://conductscience.org/library/papers/36045942 | PubMed |
| 7 | 36660543 | Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. | Clin Interv Aging | 2023 | https://conductscience.org/library/papers/36660543 | PubMed |
| 8 | 35026228 | Etiologies of insomnia in Parkinson's disease - Lessons from human studies and animal models. | Exp Neurol | 2022 | https://conductscience.org/library/papers/35026228 | PubMed |
| 9 | 36468650 | Transdiagnostic cognitive behavioral therapy for nightmares and parasomnias. | J Clin Sleep Med | 2023 | https://conductscience.org/library/papers/36468650 | PubMed |
| 10 | 33754375 | Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder. | Mov Disord | 2021 | https://conductscience.org/library/papers/33754375 | PubMed |
| 11 | 37802998 | Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization. | Transl Psychiatry | 2023 | https://conductscience.org/library/papers/37802998 | PubMed |
| 12 | 22290743 | Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease. | Mov Disord | 2012 | https://conductscience.org/library/papers/22290743 | PubMed |
| 13 | 23056363 | Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum. | PLoS One | 2012 | https://conductscience.org/library/papers/23056363 | PubMed |
| 14 | 31674060 | Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial. | Mov Disord | 2020 | https://conductscience.org/library/papers/31674060 | PubMed |
| 15 | 28559480 | In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist. | J Pharmacol Exp Ther | 2017 | https://conductscience.org/library/papers/28559480 | PubMed |
| 16 | 39650051 | Effect of zonisamide on sleep and rapid eye movement sleep behavioral disorders in patients with Parkinson's disease: A randomized control trial. | Clin Park Relat Disord | 2024 | https://conductscience.org/library/papers/39650051 | PubMed |
| 17 | 38942041 | Sleep and sleep disorders in people with Parkinson's disease. | Lancet Neurol | 2024 | https://conductscience.org/library/papers/38942041 | PubMed |
| 18 | 23388588 | [Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2012 | https://conductscience.org/library/papers/23388588 | PubMed |
| 19 | 23890176 | Therapeutic effect of Yang-Xue-Qing-Nao granules on sleep dysfunction in Parkinson's disease. | Chin Med | 2013 | https://conductscience.org/library/papers/23890176 | PubMed |
| 20 | 36503403 | Common Sleep Disorders Affecting Older Adults. | Perm J | 2023 | https://conductscience.org/library/papers/36503403 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42338732 | Parkinson's disease beyond motor symptoms: a review of the validity and limitations of current classification of non-motor symptoms. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42338732 | PubMed |
| 41668031 | Correction: Sleep disorders in parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. | BMC Neurol | 2026 | https://conductscience.org/library/papers/41668031 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41398241
GET https://conductscience.org/api/papers/v1/41398241/references?page=2